Results 161 to 170 of about 4,754 (217)

Self-reporting of hearing loss and tinnitus in the diagnosis of ototoxicity by meglumine antimoniate in patients treated for American tegumentary Leishmaniasis. [PDF]

PLoS One
Duarte CCJ, Torraca TSS, Bezerra DO, Oliveira RB, Leite NKS, de Oliveira RVC, Araújo-Melo MH, Pimentel MIF, Costa ADD, Vasconcellos ÉCF, Lyra MR, Soares ECDA, Paes LRDNB, Salgueiro MM, Schubach AO, Valete CM.   +15 more
europepmc   +1 more source

Hypersensitivity eosinophilic myocarditis possibly triggered by meglumine antimoniate

Travel Medicine and Infectious Disease
Sergio A. Bolivar-Lozano, Leidy J. Medina-Lozano, Merardo Andrés Vega Báez, Diego A. Vargas-Hernández, Oscar Galves, Ana Catalina Herrera, Álvaro A. Faccini-Martínez   +6 more
openaire   +3 more sources

Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensis. [PDF]

Int J Parasitol Drugs Drug Resist
Peixoto JF, Gonçalves-Oliveira LF, Souza-Silva F, de Castro Côrtes LM, Finkelstein LC, Dias-Lopes G, Patricio BFC, Lima CGS, Rocha HVA, da Silva FC, Ferreira VF, Pereira BAS, Alves CR.   +12 more
europepmc   +1 more source

[Meglumine antimoniate].

Revista da Sociedade Brasileira de Medicina Tropical, 2001
openaire   +1 more source

Miltefosine in visceral leishmaniasis.

, 2003
Bryceson, Anthony DM, Engel, Jurgen, Olliaro, Piero L, Ridley, Robert G, Sindermann, Herbert   +4 more
core   +1 more source

Trypanothione Reductase Gene Mutations in Meglumine Antimoniate Resistant Isolates from Cutaneous Leishmaniasis Patients Using Molecular Dynamics Method. [PDF]

Iran J Parasitol, 2020
Fozongari F, Dalimi A, Arab SS, Behmanesh M, Khammari A.   +4 more
europepmc   +1 more source

[Miltefosine or meglumine antimoniate in leishmaniasis].

Medicina, 2015
Beuy, Joob, Viroj, Wiwanitkit
openaire   +1 more source

Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis. [PDF]

Int J Parasitol Drugs Drug Resist, 2019
Goyonlo VM, Vahabi-Amlashi S, Taghavi F.
europepmc   +1 more source

Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis. [PDF]

PLoS Negl Trop Dis, 2019
Brito NC, Machado de Assis TS, Rabello A, Cota G.   +3 more
europepmc   +1 more source